BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Soligenix Announces Closing of $5,115,000 Concurrent Registered Direct Offering and Private Placement of Common Stock Priced Above Market

  Lead investors in the financing included Knoll Capital Management, LP and ACT Capital Management, LLLP.

  November 3, 2017

   · 

  5 min read
• Policy

  Jazz Pharma Submits Vyxeos Marketing Authorization Application to EMA for Treatment of Certain Types of High-Risk AML

  The CHMP granted Vyxeos accelerated assessment, which is designed to reduce the review timeline for products of major interest for public health and therapeutic innovation.

  November 3, 2017

   · 

  6 min read
• 

  Policy

  Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA

  The MAA will be reviewed under the EMA’s Accelerated Assessment program.

  November 3, 2017

   · 

  8 min read
• Genetown

  X4 Pharma Release: First Clinical Data From Combination of X4P-001-IO and Keytruda (pembrolizumab) in Patients With Melanoma Will Be Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

  X4P-001, an Orally Bioavailable CXCR4 Antagonist, Increases T-cell Infiltration in Human Metastatic Melanoma

  November 3, 2017

   · 

  3 min read
• Biotech Bay

  Bigfoot Biomedical Presents Data From Clinical Research Center Trial and Simulation Modeling at Diabetes Technology Meeting

  The trial provided validation for Bigfoot’s groundbreaking in-silico metabolic simulation engine.

  November 3, 2017

   · 

  3 min read
• Business

  Merck and CDRD Announce Joint Investment in the Canadian Life Sciences Ecosystem

  The Centre for Drug Research and Development, announced the establishment of a new $1.5M Merck-CDRD Innovation Fund.

  November 3, 2017

   · 

  4 min read
• Business

  Bio-Path Holdings to Announce Third Quarter 2017 Financial Results on November 10, 2017

  A live audio webcast of the call will be available on the Presentations section of the Company’s website.

  November 3, 2017

   · 

  1 min read
• Drug Development

  Presentations at ASN Kidney Week 2017 Highlight ChemoCentryx Platform in Treatment of Kidney Diseases ANCA-Associated Vasculitis and Focal Segmental Glomerulosclerosis (FSGS)

  The world’s premier nephrology meeting is being held October 31 to November 5 in New Orleans, LA.

  November 3, 2017

   · 

  7 min read
• 

  Policy

  Sarepta Therapeutics and Nationwide Children’s Hospital Announce FDA Clearance of the IND Application for the GALGT2 Gene Therapy Program

  Nationwide Children’s Hospital is on track to initiate a Phase 1/2a clinical trial in individuals with Duchenne muscular dystrophy by year-end 2017.

  November 3, 2017

   · 

  7 min read
• Business

  Editas Medicine to Host Conference Call Discussing Third Quarter 2017 Corporate Update and Results

  The conference call will be held on Tuesday, November 7, 2017, at 5:00 p.m. ET to discuss a corporate update and results for the third quarter of 2017.

  November 3, 2017

   · 

  1 min read